Strengthening Alzheimer’s Disease Treatment Pathways in East Asia
A new generation of treatments has the potential to change how Alzheimer’s is managed, but success depends on early detection, diagnosis and care co-ordination. As countries across East Asia find innovative ways to make this happen, a Confluence Health Consulting report identifies examples of policies that could provide practical lessons across the region.
In ageing societies across East Asia, the burden of Alzheimer’s and other dementias is growing. This has wide-reaching impacts not just for patients themselves, but for the healthcare and long-term care systems supporting them, as well as families and social structures through informal caring responsibilities.
The emergence of disease-modifying therapies (DMTs) creates an opportunity to intervene earlier in the disease course, potentially slowing progression and reducing the long-term burden on individuals, families and public systems.
However, the success of these treatments depends on strong systems for earlier detection and diagnosis. In most East Asian countries, systems are not yet fully aligned with the requirements of disease-modifying treatment, because existing pathways were designed around managing disease symptoms. Closing this readiness gap requires targeted adaptation of diagnostic capacity, specialist services and treatment infrastructure, as well as better co-ordination across health and long-term care systems.
Confluence Health Consulting prepared a report to examine how jurisdictions across East Asia are managing the transition towards earlier detection and treatment. Encouragingly, it identifies several areas where policy is already innovating and adapting in response. It then examines ten of these ‘policy exemplars’ and the practical lessons they may offer elsewhere.
These exemplars address common challenges including uneven early detection, variable access to advanced diagnostics, specialist workforce constraints, lack of follow up on referrals, data-integration challenges and financing arrangements that can be difficult to align with earlier intervention and ongoing monitoring.
Areas covered by the exemplars include:
Co-ordinated national action plans that span sectors and are enshrined in law
Early cognitive screening programs embedded within health infrastructure, delivered in the community and supported by digital technology
Linking early detection with patient referral pathways and care co-ordination
Using community-level dementia centres and specialised dementia centres as care pathway co-ordinators
Nationally co-ordinated dementia data and registry architecture to improve system-level visibility across dementia prevalence, service use, diagnostic pathways and real-world evidence
While each jurisdiction operates within a different healthcare and long-term care context, these examples demonstrate practical opportunities to adapt exemplars to their own systems, improving outcomes for patients while helping health and care systems remain sustainable over the long term.
For more information, please contact Franz Pichler on fpichler@confluencehealthconsulting.com
